The Fight Against COVID19
23.84k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
TREA analyzes over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: FDA (Food and Drug Administration), NIH (National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2 among others.
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| The Fight Against COVID19 | -1.51% | - | - | - |
| ^GSPC | -0.29% | +0.18% | +26.42% | +5941.14% |
14 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 166.15 | -0.92 | -0.55% | 4:00 p.m. EDT | 4.72M | 6.81M | 399.96B |
| ABBV | AbbVie Inc. | 192.94 | -0.51 | -0.26% | 4:00 p.m. EDT | 2.47M | 5.19M | 340.80B |
| PFE | Pfizer Inc. | 29.75 | -0.08 | -0.27% | 4:00 p.m. EDT | 22.12M | 31.61M | 168.58B |
| SNY | Sanofi | 57.47 | +0.56 | +0.98% | 4:00 p.m. EDT | 1.32M | 2.13M | 144.07B |
| REGN | Regeneron Pharmaceuticals, Inc. | 1138.81 | -7.94 | -0.69% | 4:00 p.m. EDT | 328.03k | 460.93k | 125.54B |
| GILD | Gilead Sciences, Inc. | 83.89 | +0.84 | +1.01% | 4:00 p.m. EDT | 9.19M | 7.03M | 104.44B |
| GSK | GSK plc | 42.43 | -0.13 | -0.31% | 4:00 p.m. EDT | 3.36M | 3.54M | 86.73B |
| TAK | Takeda Pharmaceutical Company Limited | 14.82 | -0.03 | -0.20% | 4:00 p.m. EDT | 1.57M | 2.12M | 46.98B |
| BNTX | BioNTech SE | 115.62 | -9.09 | -7.29% | 4:00 p.m. EDT | 1.90M | 910.46k | 27.49B |
| MRNA | Moderna, Inc. | 69.86 | -2.13 | -2.96% | 4:00 p.m. EDT | 4.25M | 4.39M | 26.85B |
| NVAX | Novavax, Inc. | 12.56 | -0.37 | -2.86% | 4:00 p.m. EDT | 5.32M | 7.01M | 2.01B |
| VIR | Vir Biotechnology, Inc. | 7.8 | -0.13 | -1.64% | 4:00 p.m. EDT | 825.52k | 920.97k | 1.07B |
| INO | Inovio Pharmaceuticals, Inc. | 6.77 | -0.01 | -0.15% | 4:00 p.m. EDT | 202.61k | 364.28k | 175.78M |
Motley FoolNovo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
This strategic play will take time to pay off, but it could keep growth going.
Pharmaceutical TechnologyLupin and Takeda to commercialise Vonoprazan in India
Vonoprazan will be made available in 10mg and 20mg strengths.
Clinical Trials ArenaMpox: Three ongoing vaccine trials to watch
As the World Health Organization (WHO) has declared mpox an emergency, the Clinical Trials Arena team investigates ongoing vaccine trials.
Sign in to view your followed lists
© 2024 Yahoo. All rights reserved.